Epigallocatechin-3-gallate (egcg) inhibits aggregation of pulmonary fibrosis associated mutant surfactant protein a2 through a proteasome degradation pathway

Publication date: September 2018Source: Pathophysiology, Volume 25, Issue 3Author(s): Yongyu Wang, Lan Li, Li Dong, Xiaofang Fan, Yongsheng Gong

Source: Pathophysiology - August 31, 2018 Category: Pathology Source Type: research